Suzanna Lee

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Childhood Cancer

Top Venues

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ precision oncology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Lindsey M Charo, Ramez N Eskander, Jason K Sicklick, Ki Hwan Kim, Hyo Jeong Lim, Ryosuke Okamura, Suzanna Lee, Rupa Subramanian, Richard B Schwab, Rebecca Shatsky, Steven Plaxe, Shumei Kato, Razelle Kurzrock
Real-World Data From a Molecular Tumor Board: Improved Outcomes in Breast and Gynecologic Cancers Patients With Precision Medicine. JCO precision oncology 6 (2022)
Bryan H Louie, Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim, Ryosuke Okamura, Ramez N Eskander, Gregory Botta, Hitendra Patel, Suzanna Lee, Scott M Lippman, Jason K Sicklick, Razelle Kurzrock
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy. NPJ precision oncology 6 (1) (2022)
Shumei Kato, Caroline Weipert, Sophia Gumas, Ryosuke Okamura, Suzanna Lee, Jason K Sicklick, Jennifer Saam, Razelle Kurzrock
Therapeutic Actionability of Circulating Cell-Free DNA Alterations in Carcinoma of Unknown Primary. JCO precision oncology 5 (2021)
Shumei Kato, Jacob J Adashek, Justin Shaya, Ryosuke Okamura, Rebecca E Jimenez, Suzanna Lee, Jason K Sicklick, Razelle Kurzrock
Concomitant MEK and Cyclin Gene Alterations: Implications for Response to Targeted Therapeutics. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (10) (2021)
Paul J Riviere, Aaron M Goodman, Ryosuke Okamura, Donald A Barkauskas, Theresa J Whitchurch, Suzanna Lee, Noor Khalid, Rachel Collier, Manvita Mareboina, Garrett M Frampton, David Fabrizio, Andrew B Sharabi, Shumei Kato, Razelle Kurzrock
High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers. Molecular cancer therapeutics 19 (10) (2020)